[On the demonstration of treatment effectivity in heterogeneous patient spot-checks].
D002328:Carisoprodol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004358:Drug Therapy; D005260:Female; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008433:Mathematics; D008620:Meprobamate / Q000627:therapeutic use; D010919:Placebos
D010919:Placebos; D002328:Carisoprodol; D008238:Lysergic Acid Diethylamide; D008620:Meprobamate
Zum Nachweis von Behandlungswirkungen bei heterogenen Patientenstichproben.